Soterix Medical
Private Company
Total funding raised: $4.3M
Overview
Soterix Medical is a private, revenue-generating medical device company focused on the neuroscience and neuromodulation sector. Its core business is providing high-precision, research-grade hardware (e.g., tDCS, HD-tES, TMS, tFUS devices) and sophisticated neurotargeting software to academic, clinical, and research institutions globally. The company has built a comprehensive portfolio that spans from foundational 1x1 tDCS systems to cutting-edge platforms like Temporal Interference Stimulation for deep brain targets, alongside synergistic monitoring technologies like EEG and fNIRS. Its strategy involves supporting the scientific community with tools for clinical trials and human performance testing while developing user-friendly solutions for clinical treatment.
Technology Platform
Integrated ecosystem of non-invasive neuromodulation hardware (tDCS, HD-tES, TMS, tFUS, TI) and brain monitoring technologies (EEG, fNIRS), coupled with proprietary neurotargeting and electric field modeling software for personalized stimulation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Soterix competes in specialized segments against companies like Neuroelectrics (tES), MagVenture & Brainsway (TMS), and various fNIRS/EEG manufacturers. Its differentiation lies in its comprehensive multi-modal platform, strong focus on research, and advanced neurotargeting software, though it faces larger competitors with greater commercial scale in therapeutic markets.